Skip to main content

MetLife Investment Management, LLC

Position in DSGN — Design Therapeutics, Inc.

CIK 1529735 Whippany, NJ

Position in DSGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$162,249
+$19,214 QoQ
Shares Held
15,249
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MetLife Investment Management, LLC holds $374,503,407 across 207 Biotechnology names. DSGN ranks #169 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DSGN

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $162,249 15,249
2025-12-31 $143,035 15,249
2025-09-30 $77,709 10,320
2025-03-31 $73,193 18,962
2024-12-31 $119,290 19,334
2024-09-30 $104,016 19,334
2024-06-30 $0 0
2023-06-30 $138,883 22,045
2023-03-31 $127,199 22,045
2022-12-31 $226,181 22,045
2022-09-30 $368,592 22,045
2022-06-30 $236,390 16,885
2022-03-31 $272,692 16,885
2021-12-31 $232,598 10,864